Recombinant poxvirus and streptococcal m protein vaccine

Details Recombinant poxvirus and streptococcal m protein vaccine Recombinant poxvirus and streptococcal m protein vaccine

C - Chemistry, Metallurgy

12

N

167/129, 530/13,

C12N 15/31 (2006.01) A61K 39/09 (2006.01) A61K 39/275 (2006.01) A61K 39/285 (2006.01) C07K 14/315 (2006.01) C12N 7/01 (2006.01) C12N 15/863 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2035039

Viruses of the family poxviridae such as vaccinia or fowlpox viruses are modified to contain a gene which expresses a protein corresponding to the conserved exposed region of the M6 protein. The modified products are useful as vaccines against streptococcal infection.

On modifie des virus de la famille des poxviridae, tels que le virus de la vaccine ou l'avipoxvirus, pour qu'il contienne un gène exprimant une protéine correspondant à la région exposée conservée de la protéine M6. Les produits modifiés sont utiles en tant que vaccins contre les infections streptococciques.

Affiliated with

Also associated with

Rating

Recombinant poxvirus and streptococcal m protein vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant poxvirus and streptococcal m protein vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant poxvirus and streptococcal m protein vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1684640